Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. - Wikidata - wikimedia - TriplyDB

Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.

Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.

http://www.wikidata.org/entity/Q33658348

about

Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations The Krüppel-like factors in female reproductive system pathologies Prevalence of uterine myomas in women in Germany: data of an epidemiological study.Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells.Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop.Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.Klf10 and Klf11 as mediators of TGF-beta superfamily signaling.Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Acceleration of the glycolytic flux by steroid receptor coactivator-2 is essential for endometrial decidualization.The role of progesterone signaling in the pathogenesis of uterine leiomyoma Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells.Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy Krüppel-like factor 12 is a novel negative regulator of forkhead box O1 expression: a potential role in impaired decidualization.Ovarian FAM110C (family with sequence similarity 110C): induction during the periovulatory period and regulation of granulosa cell cycle kinetics in rats.Phenotypic Characterization of Mice Carrying Homozygous Deletion of KLF11, a Gene in Which Mutations Cause Human Neonatal and MODY VII Diabetes.Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation.Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.Ulipristal acetate: in uterine fibroids.The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.KLF11 is an Epigenetic Mediator of DRD2/Dopaminergic Signaling in Endometriosis.Promoter DNA methylation is associated with KLF11 expression in epithelial ovarian cancer.KLF11 epigenetically regulates glycodelin-A, a marker of endometrial biology via histone-modifying chromatin mechanisms.KLF10 Mediated Epigenetic Dysregulation of Epithelial CD40/CD154 Promotes Endometriosis.LAT1 regulates growth of uterine leiomyoma smooth muscle cells.Clinical correlates of leiomyoma estrogen and progesterone receptors among Nigerian women.miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family.The Rising Phoenix-Progesterone as the Main Target of the Medical Therapy for Leiomyoma.A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas.Epigenetic Modulation of Collagen 1A1: Therapeutic Implications in Fibrosis and Endometriosis.

P2860

Q24567733-8D2AB89D-0752-4E75-95C0-F25F43F14E94 Q26853244-DC9FFCB1-94AA-47B7-97C5-14F2FC7C90A4 Q31015107-1669B84C-80C0-41A5-AA94-3AB82B2D5C07 Q33589684-C3C05451-0931-4B32-94FD-30F13B8A94F5 Q33826227-B2B8931C-E578-463F-85BA-26309FD3C74B Q34124951-846D9D67-819E-4393-ADE0-59132FA80BB7 Q34137268-3A5DD41B-C8D3-47A4-9FE4-19D5F72DD6E5 Q34185182-6C739FEE-7150-4F09-B0CE-CFCC308455EF Q34200701-84BF61C3-612D-4BC5-AF40-5F9C129108A1 Q34321877-BB176745-EEA3-4B0B-96D2-303AF8F4E121 Q34337117-3EB4AE76-10B4-4711-BF62-6884825B1036 Q34437666-35586978-8C53-4A3B-B88C-2D30290FA4E2 Q35034354-C73B100E-14B2-42C6-B942-E32B2997FFBC Q35249360-E271EB1A-3AAC-4515-8EA6-0F0388DE7554 Q35603392-4449728E-758B-47BD-A87A-14104B1EA2BB Q35855640-5F13BC63-09C8-47D4-807D-E3F0B1F65830 Q35902872-6907BDCE-5358-46C5-B675-27C45140C5A5 Q36066533-CACC0957-F163-4E42-ABFB-0F51E2E72AC7 Q36107457-05861F9B-2F46-4B95-AE64-6D2D4D22D86D Q36298532-EE08F7F9-A31F-4B89-9300-E5C6D381E1F3 Q36794310-F22275C8-0419-44F8-BB8A-B5ED7B4CBEDD Q37218723-409AB452-4B10-4459-A32B-08780C1118D8 Q38008475-D29470FD-EE1B-4341-BED4-EF16647CE9DA Q38448187-66EFC5BC-97FE-46F8-88F6-B5C437EF0CCC Q38709125-928B38FB-279F-4A85-8B37-613EA639A429 Q38880302-2CC773F3-6B9F-4744-B518-00A49B8719A7 Q39092744-04897F6B-A46C-49FD-B439-484ADA2180E8 Q39528324-8F8EBAAF-5612-4D4A-B710-8E07556C98DE Q42986682-C3BAE0B9-E957-4289-8BD4-48C72889E143 Q46949231-DD0A873B-7F97-41FA-8390-06E512C7B2D4 Q47235299-8E45D9CA-9DBD-4CF1-BDFF-02BBA350B552 Q47561375-87E6EDEA-E74C-4FEE-B671-8C98649994E9 Q47793478-24069AA3-6F6E-4DA0-8AF0-CB5BE5E99EFE Q52882350-2C88459D-4E14-492C-B34E-B0DB5FFCA7BE

P2860

Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.

http://www.wikidata.org/entity/Q33658348

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Transcription factor KLF11 int ...... on in uterine leiomyoma cells.

@ast

Transcription factor KLF11 int ...... on in uterine leiomyoma cells.

@en

type

label

Transcription factor KLF11 int ...... on in uterine leiomyoma cells.

@ast

Transcription factor KLF11 int ...... on in uterine leiomyoma cells.

@en

prefLabel

Transcription factor KLF11 int ...... on in uterine leiomyoma cells.

@ast

Transcription factor KLF11 int ...... on in uterine leiomyoma cells.

@en

P1433

Q33658348-DFBB7B9F-9670-405E-8A5B-96EFF17F768F

P1476

Q33658348-B310F266-BC00-4537-8703-A119106E5760

P2093

Q33658348-1FB3652D-E5CC-4475-AC82-21D662FB67F5

Q33658348-23F46B50-2CD6-4DE3-A1BE-525844CA307A

Q33658348-341978C4-8628-441A-B9C1-346A21F098BE

Q33658348-347D9C0D-AE85-4012-BA97-182993A0FA94

Q33658348-38686C18-1042-4362-AA16-E768ABAF4D4F

Q33658348-8388F749-6CD6-41E4-A64A-E7869DC4AF91

Q33658348-8F779B08-0834-45B1-8BCF-44EFA71A6AE4

Q33658348-9E4DC368-BAE6-4C1A-ADF4-EC6233D10828

Q33658348-A3A5F3C2-2F15-4ADF-9E6A-858059C995B6

Q33658348-A937FEAC-0E10-497B-BC7F-978FE42DE27F

P2860

Q33658348-0224AA41-BAA0-4A3F-B0C1-FA03A78E77A2

Q33658348-04624855-DA10-4124-BD51-D055930EB0B7

Q33658348-112AA742-B415-43D2-A426-AF6B74A7EAEE

Q33658348-15C23F74-6B77-42F4-9D7B-71DBD38BF0EB

Q33658348-1B88BB82-8DF5-4CC6-9B20-E2E9585D1AA6

Q33658348-1D237AC2-300E-4A1B-A9AF-FA6255ABB0F0

Q33658348-288375B4-BFFA-4743-A7A8-B91E431BB18C

Q33658348-2CF6D4D0-3295-4C03-8ECD-383A3C7EBF4D

Q33658348-2D289FA0-E2CE-4E01-8A5B-D50CD23FA46F

Q33658348-30BEF839-08D1-4AAA-B2B6-10A5FF3F6DB2

P304

Q33658348-53673744-49BA-4878-9CEF-C277BCD85F8B

P31

Q33658348-BE9ECAD8-1A33-440E-B30F-ECF9F5A9842F

P356

Q33658348-D0153A9A-6AED-4FF8-876B-E112F4CF8E28

P407

Q33658348-3F5594D5-9ED9-4366-8E8A-00516B5826C9

P433

Q33658348-4026E1B2-F520-482F-A7EE-42F8A5D8DAB3

P478

Q33658348-CE6EF101-45C2-4480-AFF1-6219FA3CB4DB

P577

Q33658348-ADF4E5BC-A5D9-4FBC-82D4-56B320A4B259

P5875

Q33658348-49D57D57-17EA-42AF-8CEE-789A50D4B90A

P698

Q33658348-22D19433-99D1-48D7-8F64-4BD7DBEAAC50

P932

Q33658348-BFE2EB28-B349-461B-9CD3-86653927578F

P356

0008-5472.CAN-09-2612

P1433

Cancer Research

P1476

Transcription factor KLF11 int ...... on in uterine leiomyoma cells.

@en

P2093

Debabrata Chakravarti

http://www.w3.org/2001/XMLSchema#string

Erica E Marsh

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ishikawa

http://www.w3.org/2001/XMLSchema#string

J Julie Kim

http://www.w3.org/2001/XMLSchema#string

John Sayler Coon

http://www.w3.org/2001/XMLSchema#string

Joy Innes

http://www.w3.org/2001/XMLSchema#string

Ju Wu

http://www.w3.org/2001/XMLSchema#string

Kerry Pearson

http://www.w3.org/2001/XMLSchema#string

Ping Yin

http://www.w3.org/2001/XMLSchema#string

Scott Reierstad

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells

Characterization of a cDNA encoding a novel human Golgi alpha 1, 2-mannosidase (IC) involved in N-glycan biosynthesis

Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells

Isolation of estrogen-responsive genes with a CpG island library

Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells

Sox8 is a specific marker for muscle satellite cells and inhibits myogenesis

P304

1722-1730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-2612

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41399574

http://www.w3.org/2001/XMLSchema#string

P698

20124487

http://www.w3.org/2001/XMLSchema#string

P932

2822899

http://www.w3.org/2001/XMLSchema#string